Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.
2.

Treatment evaluation of Wharton's jelly-derived mesenchymal stem cells using a chronic salpingitis model: an animal experiment.

Li Z, Zhang Z, Chen X, Zhou J, Xiao XM.

Stem Cell Res Ther. 2017 Oct 17;8(1):232. doi: 10.1186/s13287-017-0685-0.

3.

Tracing GFP-labeled WJMSCs in vivo using a chronic salpingitis model: an animal experiment.

Li Z, Zhang Z, Ming WK, Chen X, Xiao XM.

Stem Cell Res Ther. 2017 Dec 1;8(1):272. doi: 10.1186/s13287-017-0714-z.

4.

Intravenous vs intraperitoneal transplantation of umbilical cord mesenchymal stem cells from Wharton's jelly in the treatment of streptozotocin-induced diabetic rats.

El-Hossary N, Hassanein H, El-Ghareeb AW, Issa H.

Diabetes Res Clin Pract. 2016 Nov;121:102-111. doi: 10.1016/j.diabres.2016.09.008. Epub 2016 Sep 21.

PMID:
27693839
5.

Human umbilical cord Wharton's jelly-derived mesenchymal stem cells differentiate into a Schwann-cell phenotype and promote neurite outgrowth in vitro.

Peng J, Wang Y, Zhang L, Zhao B, Zhao Z, Chen J, Guo Q, Liu S, Sui X, Xu W, Lu S.

Brain Res Bull. 2011 Feb 28;84(3):235-43. doi: 10.1016/j.brainresbull.2010.12.013. Epub 2010 Dec 29.

PMID:
21194558
6.

Xenograft of human umbilical mesenchymal stem cells from Wharton's jelly as a potential therapy for rat pilocarpine-induced epilepsy.

Huang PY, Shih YH, Tseng YJ, Ko TL, Fu YS, Lin YY.

Brain Behav Immun. 2016 May;54:45-58. doi: 10.1016/j.bbi.2015.12.021. Epub 2015 Dec 28.

7.

The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.

Fan YP, Hsia CC, Tseng KW, Liao CK, Fu TW, Ko TL, Chiu MM, Shih YH, Huang PY, Chiang YC, Yang CC, Fu YS.

Stem Cells Transl Med. 2016 Feb;5(2):235-47. doi: 10.5966/sctm.2015-0001. Epub 2015 Dec 30.

8.

Reduction of fibrosis in dibutyltin dichloride-induced chronic pancreatitis using rat umbilical mesenchymal stem cells from Wharton's jelly.

Zhou CH, Li ML, Qin AL, Lv SX, Wen-Tang, Zhu XY, Li LY, Dong Y, Hu CY, Hu DM, Wang SF.

Pancreas. 2013 Nov;42(8):1291-302. doi: 10.1097/MPA.0b013e318296924e.

PMID:
24152954
9.

Improvement in Therapeutic Ability of Wharton's Jelly Derived Mesenchymal Stem Cells with Vitamin E in Breast Cancer.

Wajid N, Azam M, Khalid S, Ali F, Qazi A, Qazi MH.

J Coll Physicians Surg Pak. 2017 Dec;27(12):754-758. doi: 2766.

PMID:
29185401
10.

Cellular activity of Wharton's Jelly-derived mesenchymal stem cells on electrospun fibrous and solvent-cast film scaffolds.

Bagher Z, Ebrahimi-Barough S, Azami M, Safa M, Joghataei MT.

J Biomed Mater Res A. 2016 Jan;104(1):218-26. doi: 10.1002/jbm.a.35555. Epub 2015 Sep 18.

PMID:
26265047
11.

Chronic Myeloid Leukemia Blood Inflicted Injury in Cord Derived Wharton's Jelly Mesenchymal Stem Cells.

Wajid N, Ali M, Javed S, Ali F, Anwar SS.

J Coll Physicians Surg Pak. 2016 May;26(5):361-5. doi: 2315.

PMID:
27225138
12.

Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1.

Zou X, Zhang G, Cheng Z, Yin D, Du T, Ju G, Miao S, Liu G, Lu M, Zhu Y.

Stem Cell Res Ther. 2014 Mar 19;5(2):40. doi: 10.1186/scrt428.

13.
14.

Isolation and characterization of canine Wharton's jelly-derived mesenchymal stem cells.

Seo MS, Park SB, Kang KS.

Cell Transplant. 2012;21(7):1493-502.

PMID:
22732242
15.

Application potential of mesenchymal stem cells derived from Wharton's jelly in liver tissue engineering.

Zhang L, Zhao YH, Guan Z, Ye JS, de Isla N, Stoltz JF.

Biomed Mater Eng. 2015;25(1 Suppl):137-43. doi: 10.3233/BME-141232. Review.

PMID:
25538064
16.

Safety and Efficacy of Human Wharton's Jelly-Derived Mesenchymal Stem Cells Therapy for Retinal Degeneration.

Leow SN, Luu CD, Hairul Nizam MH, Mok PL, Ruhaslizan R, Wong HS, Wan Abdul Halim WH, Ng MH, Ruszymah BH, Chowdhury SR, Bastion ML, Then KY.

PLoS One. 2015 Jun 24;10(6):e0128973. doi: 10.1371/journal.pone.0128973. eCollection 2015.

17.

Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction.

Zhang W, Liu XC, Yang L, Zhu DL, Zhang YD, Chen Y, Zhang HY.

Coron Artery Dis. 2013 Nov;24(7):549-58. doi: 10.1097/MCA.0b013e3283640f00.

PMID:
23892469
18.

Wharton's jelly-derived mesenchymal stem cells combined with praziquantel as a potential therapy for Schistosoma mansoni-induced liver fibrosis.

Hammam OA, Elkhafif N, Attia YM, Mansour MT, Elmazar MM, Abdelsalam RM, Kenawy SA, El-Khatib AS.

Sci Rep. 2016 Feb 15;6:21005. doi: 10.1038/srep21005. Erratum in: Sci Rep. 2016 Sep 02;6:32052.

19.

Generating CK19-positive cells with hair-like structures from Wharton's jelly mesenchymal stromal cells.

Aljitawi OS, Xiao Y, Zhang D, Stehno-Bittel L, Garimella R, Hopkins RA, Detamore MS.

Stem Cells Dev. 2013 Jan 1;22(1):18-26. doi: 10.1089/scd.2012.0184. Epub 2012 Oct 19.

PMID:
22970796
20.

Mitochondrial transfer from Wharton's jelly-derived mesenchymal stem cells to mitochondria-defective cells recaptures impaired mitochondrial function.

Lin HY, Liou CW, Chen SD, Hsu TY, Chuang JH, Wang PW, Huang ST, Tiao MM, Chen JB, Lin TK, Chuang YC.

Mitochondrion. 2015 May;22:31-44. doi: 10.1016/j.mito.2015.02.006. Epub 2015 Mar 3.

PMID:
25746175

Supplemental Content

Support Center